Prospects and challenges of in vivo hematopoietic stem cell genome editing for hemoglobinopathies.
Molecular therapy : the journal of the American Society of Gene Therapy, 31(10): 2823-2825 PMID 37729905 DOI 10.1016/j.ymthe.2023.09.006
Abstract
This article has no abstract in PubMed.